Clinical Trial: Stereotactic Aspiration and Thrombolysis of Intracerebral Hemorrhage: a Prospective Controlled Study

Study Status: Active, not recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Stereotactic Aspiration and Thrombolysis of Intracerebral Hemorrhage: a Prospective Controlled Study（SATIH）

Brief Summary: The purpose of this study is to evaluate the superiority of effect of the modified micro-invasive aspiration and drainage and conservative medical therapy in the treatment of ICH spontaneously hypertensive scientifically.

Detailed Summary:

The stereotactic computed tomographic-guided aspiration and drainage is one of the best choices in the treatment of a large-scale deep supratentorial intracerebral hematoma. It uses hardware access technology, in a relatively short time to enter the hematoma center, with suction liquefaction technology. It has the advantage of a higher clearance rate of the hematoma, simple convenience, small trauma and low-cost. We carry on the suitable improvement in this technology's foundation in view of its deficiency, the introduction of the concept of the individual, will further reduce the rate of bleeding and mortality, improve survival, such as long-term quality of life.

We will adopt scales such as the rate of rebleeding, mortality, complication,NIHSS, MRS, BI, GOS scale to analysis and evaluating efficacy and safety of this technology and conservative treatment in the treatment of HICH.

Sponsor: Huazhong University of Science and Technology

Current Primary Outcome: The rate of rebleeding and mortality, Glasgow Outcome Scale for prognosis [ Time Frame: duration of 14 days after operation(rebleeding), duration of hospital stay(mortality), 180 days after onset(mortality and GOS) ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Nation of Health Stroke Scale Score , modified Rankin Scale, Barthel Index complications [ Time Frame: the moment of admission and post operation(NIHSS), 14 days after admission(NIHSS,MRS), duration of hospital stay(complications), 180 days after onset(BI, MRS) ]

Original Secondary Outcome: Same as current

Information By: Huazhong University of Science and Technology

Dates:
Date Received: June 9, 2008
Date Started: September 2008
Date Completion: December 2010
Last Updated: September 12, 2008
Last Verified: September 2008